The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gromova O.A.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna;
kafedra farmakologii i klinicheskoĭ farmakologii Ivanovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Torshin I.Iu.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna

Kalacheva A.G.

Ivanovo State Medical Academy, Ministry of Health of Russia

Kuramshina D.B.

Molecular-biological basics of neuroprotection effects of magnesium

Authors:

Gromova O.A., Torshin I.Iu., Kalacheva A.G., Kuramshina D.B.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(12): 90‑101

Read: 10380 times

Download PDF (RU)
Contact the author
Table of contents

MOLECULAR-BIOLOGICAL BASICS OF NEUROPROTECTION EFFECTS OF MAGNESIUM
MOLECULAR-BIOLOGICAL BASICS OF NEUROPROTECTION EFFECTS OF MAGNESIUM

To cite this article:

Gromova OA, Torshin IIu, Kalacheva AG, Kuramshina DB. Molecular-biological basics of neuroprotection effects of magnesium. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(12):90‑101. (In Russ.)

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Pharmacological effe­cts of fonturacetam (Actitropil) and prospects for its clinical use. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):21-31
Stroke: current state of the problem. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):7-18
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Neurocytoprotection adva­nces in repe­rfusion therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):75-88
The known and new ideas about the mechanism of action and the spectrum of effe­cts of Mexi­dol. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):22-33
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Possibilities of physiotherapy in glaucomatous optic neuropathy after glaucoma surgery. Russian Annals of Ophthalmology. 2024;(3):88-94
Sali­vary mine­rals and caries expe­rience among adolescents in Syktyvkar, Komi Repu­blic. Stomatology. 2024;(6):48-54
Neuroprotective therapy for age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2024;(6):152-158
Neuroprotective therapy of glaucoma. Russian Annals of Ophthalmology. 2025;(1):83-90

Keywords:

magnesium
neuroprotection
neurotrophic effects
Magne B6

Authors:

Gromova O.A.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna;
kafedra farmakologii i klinicheskoĭ farmakologii Ivanovskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Torshin I.Iu.

Rossiĭskiĭ satellitnyĭ tsentr instituta mikroélementov IuNESKO;
Laboratoriia vychislitel'noĭ i sistemnoĭ biologii VTs RAN im. A.A. Dorodnitsyna

Kalacheva A.G.

Ivanovo State Medical Academy, Ministry of Health of Russia

Kuramshina D.B.

List of references:

  1. Gogoleva I.V. Vliyanie organicheskikh solei litiya, magniya, selena na elementnyi gomeostaz golovnogo mozga na fone eksperimental'noi khronicheskoi okklyuzii obshchikh sonnykh arterii: Avtoref. dis. … kand. med. nauk. M 2009; 25.
  2. Gromova O.A. Magnii i piridoksin. Osnovy znanii. M: ProtoTip 2006; 234.
  3. Gromova O.A., Kalacheva A.G., Satarina T.E. i dr. Vliyanie preparata Magne V6 na parametry stressa i kognitivnuyu funktsiyu pri vysokikh psikhoemotsional'nykh nagruzkakh. Trudnyi patsient 2008; 6: 12: 28-32.
  4. Gusev E.I., Skvortsova V.I. Ishemiya golovnogo mozga. M: Meditsina 2001; 678.
  5. Kalacheva A.G. Element-spetsificheskie indikatory neirotropnykh funktsii magniya: Avtoref. dis. … kand. med. nauk. M 2011; 23.
  6. Orlova S.V. Obespechennost' magniem po dannym otsenki ratsiona pitaniya rossiyan. Vestnik RUDN 2009.
  7. Skoromets A.A., Gromova O.A., Fedotova L.E. Potentsirovanie neiroprotektornoi terapii u bol'nykh s rannimi formami tserebrovaskulyarnoi patologii preparatom Magne V6. Ros pediat zhurn 2005; 1: 30-36.
  8. Slobodin V.B., Tomilova I.K. Patologicheskaya fiziologiya i eksperimental'naya terapiya 2007; 2: 17-19.
  9. Torshin I.Yu., Gromova O.A. Dvadtsat' pyat' mgnovenii molekulyarnoi farmakologii. A-Grif 2011; 560.
  10. Acheson A., Conover J.C., Fandl J.P. et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature 1995; 374: 6521: 450-453.
  11. Al-Shawi R., Hafner A., Chun S., Raza S. ProNGF, Sortilin, and Age-related Neurodegeneration. Ann N Y Acad Sci 2007; 1119: 208.
  12. Altura B.M., Shah N.C., Jiang X.C. et al. Short-term magnesium deficiency results in decreased levels of serum sphingomyelin, lipid peroxidation, and apoptosis in cardiovascular tissues. Am J Physiol Heart Circ Physiol 2009; 297: 1: 86-92.
  13. Aslanyan S., Weir C.J., Muir K.W., Lees K.R. Magnesium for treatment of acute lacunar stroke syndromes: further analysis of the IMAGES trial. Stroke 2007; 38: 4: 1269-1273.
  14. Bekinschtein P., Cammarota M., Katche C. et al. BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci USA 2008; 105: 7: 2711-2716.
  15. Bhat M.A. Magnesium sulfate in severe perinatal asphyxia: a randomized, placebo-controlled trial. Pediatrics 2009; 123: 5: 764-769.
  16. Buyukokuroglu M.E., Gepdiremen A., Tastekin A., Ors R. Pyridoxine may protect the cerebellar granular cells against glutamate-induced toxicity. Int J Vitam Nutr Res 2007; 77: 5: 336-340.
  17. Cetinkaya M., Alkan T., Ozyener F. et al. Possible neuroprotective effects of magnesium sulfate and melatonin as both pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology 2011; 99: 4: 302-310.
  18. Chan M.T. Magnesium sulfate for brain protection during temporary cerebral artery occlusion. Acta Neurochir Suppl 2005; 95: 107-111.
  19. Chen S.D., Chen Y.B., Peng Y. et al. Role of PI3K/Akt signaling in the protective effect of magnesium sulfate against ischemia-perfusion injury of small intestine in rats. Chin Med J (Engl) 2010; 123: 11: 1447-1452.
  20. Committee O. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol 2010; 115: 3: 669-671.
  21. Domeniconi M., Hempstead B.L., Chao M.V. Pro-NGF secreted by astrocytes promotes motor neuron cell death. Mol Cell Neurosci 2007; 34: 2: 271-279.
  22. Doyle L.W., Crowther C.A., Middleton P., Marret S. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; 1: CD004661.
  23. Doyle L.W., Crowther C.A., Middleton P. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet Gynecol 2009; 113: 6: 1327-1333.
  24. Dribben W.H., Creeley C.E., Wang H.H. High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain. Neonatology 2009; 96: 1: 23-32.
  25. Dyckner T., Wester P.O. Effect of magnesium on blood pressure. Br Med J 1983; 286: 6381: 1847-1849.
  26. Ernfors P., Kucera J. Studies on the physiological role of brain-derived neurotrophic factor and neurotrophin-3 in knockout mice. Int J Dev Biol 1995; 39: 5: 799.
  27. Friedlich D. Retrospective analysis of parenteral magnesium sulfate administration in decreased incidence of clinical and neuroradiological cerebral vasospasm: a single center experience. Neurol Res 2009; 31: 6: 621-625.
  28. Furukawa Y., Kasai N., Torimitsu K. Effect of Mg2+ on neural activity of rat cortical and hippocampal neurons in vitro. Magnes Res 2009; 22: 3: 174-181.
  29. Garnier Y. Neuroprotective effects of magnesium on metabolic disturbances in fetal hippocampal slices after oxygen-glucose deprivation: mediation by nitric oxide system. J Soc Gynecol Investig 2002; 9: 2: 86-92.
  30. Geng M.Y., Saito H., Katsuki H. Effects of vitamin B6 and its related compounds on survival of cultured brain neurons. Neurosci Res 1995; 24: 1: 61-65.
  31. Gougoulias N., Hatzisotiriou A. Magnesium administration provokes motor unit survival, after sciatic nerve injury in neonatal rats. BMC Musculoskelet Disord 2004; 5: 1: 33.
  32. Hasegawa T., Mikoda N., Kitazawa M., LaFerla F.M. Treatment of Alzheimer's disease with anti-homocysteic acid antibody in 3xTg-AD male mice. PLoS One 2010; 5: 1: 8593.
  33. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24: 677-736.
  34. Huang C.Y. Role of ERK signaling in the neuroprotective efficacy of magnesium sulfate treatment during focal cerebral ischemia in the gerbil cortex. Clin J Physiol 2010; 53: 5: 299.
  35. Ibanez C.F. Jekyll-Hyde neurotrophins: the story of proNGF. Trends Neurosci 2002; 25: 6: 284.
  36. Jee S.H., Miller E.R. 3rd, Guallar E. et al. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens 2002; 15: 8: 691-696.
  37. Kang S.W., Choi S.K., Park E., Chae S.J. Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion. Brain Res 2011; 1371: 121-128.
  38. Knijn N., Tol J., Koopman M. The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients. Eur J Cancer 2011; 47: 3: 369-374.
  39. Kuypers N.J., Hoane M.R. Pyridoxine administration improves behavioral and anatomical outcome after unilateral contusion injury in the rat. J Neurotrauma 2010; 27: 7: 1275-1282.
  40. Lazaridis C., Naval N. Risk factors and medical management of vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am 2010; 21: 2: 353-364.
  41. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 4: 487-501.
  42. Luthringer C., Rayssiguier Y., Gueux E. Berthelot A. Effect of moderate magnesium deficiency on serum lipids, blood pressure and cardiovascular reactivity in normotensive rats. Br J Nutr 1988; 59: 2: 243-250.
  43. Lyden P., Wahlgren N.G. Mechanisms of action of neuroprotectants in stroke. J Stroke Cerebrovasc Dis 2000; 9: 6 Pt 2: 9-14.
  44. Ma L. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials. Brain Inj 2010; 24: 5: 730-735.
  45. Magee L., Sawchuck D., Synnes A., von Dadelszen P. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection. J Obstet Gynaecol Can 2011; 33: 5: 516-529.
  46. Marret S., Chollat C., Leveque C., Marpeau L. Prevention of cerebral palsy using magnesium sulfate in pre-term newborns. Arch Pediat 2011; 18: 3: 324-330.
  47. Martin H., Uring-Lambert B., Adrian M. et al. Effects of long-term dietary intake of magnesium on oxidative stress, apoptosis and ageing in rat liver. Magnes Res 2008; 21: 2: 124-130.
  48. McDonald J.W. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett 1990; 109: 1-2: 234-238.
  49. Meloni B.P., Campbell K. In search of clinical neuroprotection after brain ischemia: the case for mild hypothermia (35 degrees C) and magnesium. Stroke 2009; 40: 6: 2236-2240.
  50. Ozdemir M., Cengiz S.L., Gurbilek M. Effects of magnesium sulfate on spinal cord tissue lactate and malondialdehyde levels after spinal cord trauma. Magnes Res 2005; 18: 3: 170-174.
  51. Petersen B., Schroll M., Christiansen C., Transbol I. Serum and erythrocyte magnesium in normal elderly danish people. Relationship to blood pressure and serum lipids. Acta Med Scand 1977; 201: 1-2: 31-34.
  52. Pryde P.G., Mittendorf R. Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose. Obstet Gynecol 2009; 114: 3: 669-673.
  53. Resnick L.M. Intracellular free magnesium in erythrocytes of essential hypertension: relation to blood pressure and serum divalent cations. Proc Natl Acad Sci USA 1984; 81: 20: 6511-6515.
  54. Rude R., Manoogian C., Ehrlich L. Mechanisms of blood pressure regulation by magnesium in man. Magnesium 1989; 8: 5-6: 266-273.
  55. Sen A.P., Gulati A. Use of magnesium in traumatic brain injury. Neurotherapeutics 2010; 7: 1: 91-99.
  56. Sendowski I. Magnesium therapy in acoustic trauma. Magnes Res 2006; 19: 4: 244-254.
  57. Solaroglu I. Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats. Surg Neurol 2005; 64 Suppl 2: 17-21.
  58. Standley C.A., Batia L., Yueh G. Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia. J Matern Fetal Neonatal Med 2006; 19: 3: 171-176.
  59. Stippler M., Fischer M.R., Puccio A.M. Serum and cerebrospinal fluid magnesium in severe traumatic brain injury outcome. J Neurotrauma 2007; 24: 8: 1347-1354.
  60. Tam M., Gomez S., Gonzalez-Gross M., Marcos A. Possible roles of magnesium on the immune system. Eur J Clin Nutr 2003; 57: 10: 1193-1197.
  61. Tong G.M. Magnesium deficiency in critical illness. J Intensive Care Med 2005; 20: 1: 3-17.
  62. Torshin I.Yu. Bioinformatics in the post-genomic era: physiology and medicine. Nova Biomedical Books 2007; 1-20.
  63. Torshin I.Yu., Gromova O.A. Magnesium and pyridoxine: fundamental studies and clinical practice. Nova Science 2009; 250.
  64. Torshin I.Yu. Bioinformatics in the post-genomic era: sensing the change from molecular genetics to personalized medicine. New York: Nova Biomedical Books 2009.
  65. Turkoglu O.F. A comparative study of treatment for brain edema: magnesium sulphate versus dexamethasone sodium phosphate. J Clin Neurosci 2008; 15: 1: 60-65.
  66. Van den Bergh W.M. Magnesium and aspirin treatment in patients with subarachnoid haemorrhage. Comparison of effects after endovascular and neurosurgical aneurysm occlusion. J Neurol 2009; 256: 2: 213-216.
  67. Van Leer E.M., Seidell J.C., Kromhout D. Dietary calcium, potassium, magnesium and blood pressure in the Netherlands. Int J Epidemiol 1995; 24: 6: 1117-1123.
  68. Wang M., Yang Y., Dong Z. et al. NR2B-containing N-methyl-D-aspartate subtype glutamate receptors regulate the acute stress effect on hippocampal long-term potentiation/long-term depression in vivo. Neuroreport 2006; 17: 12: 1343-1346.
  69. Weglicki W.B., Phillips T.M. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992; 110: 2: 169-173.
  70. Weglicki W.B., Mak I.T., Phillips T.M. Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res 1994; 74: 5: 1009-1013.
  71. Wiseman D.B., Dailey A.T. Magnesium efficacy in a rat spinal cord injury model. J Neurosurg Spine 2009; 10: 4: 308-314.
  72. Wong G.K., Lam C.W., Chan M.T. et al. The effect of hypermagnesemic treatment on cerebrospinal fluid magnesium level in patients with aneurysmal subarachnoid hemorrhage. Magnes Res 2009; 22: 2: 60-65.
  73. Wu G., Tian H., Han K. et al. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension. Clin Exp Hypertens 2006; 28: 5: 489-497.
  74. Yamada K., Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci 2003; 91: 4: 267-270.
  75. Yamashima T., Zhao L., Wang X.D. et al. Neuroprotective effects of pyridoxal phosphate and pyridoxal against ischemia in monkeys. Nutr Neurosci 2001; 4: 5: 389.
  76. Yang T.T., Wang S.J. Pyridoxine inhibits depolarization-evoked glutamate release in nerve terminals from rat cerebral cortex: a possible neuroprotective mechanism? J Pharmacol Exp Ther 2009; 331: 1: 244-254.
  77. Zelaporte B., Bruel H. Effect of magnesium sulphste on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-yaer neurological jutcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil 2008; 36: 3: 278-288.
  78. Zou L.P., Wang X., Dong C.H., Chen C. Three-week combination treatment with ACTH + magnesium sulfate versus ACTH monotherapy for infantile spasms: a 24-week, randomized, open-label, follow-up study in China. Clin Ther 2010; 32: 4: 692-700.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.